About the summit
The Korea program is anchored around Bio Korea 2026, offering Nordic life science companies a focused and efficient entry point into the Korean life science market while connecting them to a truly global life science ecosystem.
The program brings together market insights, industry engagement, and high-level networking opportunities, enabling participating companies to gain a comprehensive understanding of Korea’s healthcare and life science landscape. This includes key regulatory and reimbursement frameworks, approval processes, and commercialization pathways, complemented by practical insights from local industry and ecosystem experts through on-site engagements.
Participation in Bio Korea, one of Asia’s leading life science conventions, provides access to a broad network of Korean and international pharmaceutical, biotech, and investment players. Through structured business matchmaking, alongside engagement across the exhibition floor, conference sessions, and networking platforms, companies can connect with high-caliber potential partners, investors, and key industry stakeholders from across regions.
The program also features a VIP reception at the Swedish Residence, offering an exclusive setting for relationship-building with senior decision-makers from industry, government, and the international investment community.
Throughout BIO KOREA, the National Pavilion serves as a central platform for company visibility, on-site support, and meetings, ensuring a strong joint presence and practical assistance for participating companies during the exhibition and partnering activities.